compound tirzepatide no longer available FDA Allows Compounded During Shortage Review FDA ban on compounded tirzepatide:

No insurance coordination required at any stage of the process

In the meantime, the advice remains to slip, slop, slap, seek and slide whenever the UV index reaches three or higher daily from September to April in Australias southern states and all year round further north

Medical uses are short term (e.g., acute conditions)

Tirzepatide is positioned for those seeking maximal metabolic effect or who have plateaued on semaglutide

If you experience unexpected changes in appetite suppression, energy, or side effect severity, report these to your prescriber immediately

Methods This was a register-based cross-sectional study including all inhabitants in Region Stockholm, Sweden, who were dispensed a GLP-1 RA between 2019 and 2023